Sweetgreen Is Cheap By One Metric, And I Recommend Buying The DipMiriam wanted to be a pro golfer. Instead, she’s an executive on a $26,000 salary
It looked like a recipe for disaster. So, when his country’s swimmers were being accused of doping earlier this year, one Chinese official cooked up something fast. He blamed it on contaminated noodles. In fact, he argued, it could have been a culinary conspiracy concocted by criminals, whose actions led to the cooking wine used to prepare the noodles being laced with a banned heart drug that found its way into an athlete’s system. This theory was spelled out to international anti-doping officials during a meeting and, after weeks of wrangling, finally made it into the thousands of pages of data handed over to the lawyer who investigated the who had tested positive for that same drug. The attorney, appointed by the World Anti-Doping Agency, refused to consider that scenario as he sifted through the evidence. In spelling out his reasoning, lawyer Eric Cottier paid heed to the half-baked nature of the theory. “The Investigator considers this scenario, which he has described in the conditional tense, to be possible, no less, no more,” Cottier wrote. Even without the contaminated-noodles theory, Cottier found problems with the way WADA and the Chinese handled the case but ultimately determined WADA in not appealing China’s conclusion that its athletes had been inadvertently contaminated. Critics of the way the China case was handled can’t help but wonder if a wider exploration of the noodle theory, details of which were discovered by The Associated Press via notes and emails from after the meeting where it was delivered, might have lent a different flavor to Cottier’s conclusions. “There are more story twists to the ways the Chinese explain the TMZ case than a James Bond movie,” said Rob Koehler, the director general of the advocacy group Global Athlete. “And all of it is complete fiction.” Something in the kitchen was contaminated In April, reporting from the New York Times and the German broadcaster ARD revealed that the 23 Chinese swimmers had tested positive for the banned heart medication trimetazidine, also known as TMZ. China’s anti-doping agency determined the athletes had been contaminated, and so, did not sanction them. , did not press the case further, and China was never made to deliver a public notice about the “no-fault findings,” as is often seen in similar cases. The stock explanation for the contamination was that traces of TMZ were found in the kitchen of a hotel where the swimmers were staying. In , Cottier relayed some suspicions about the feasibility of that chain of events — noting that WADA’s chief scientist “saw no other solution than to accept it, even if he continued to have doubts about the reality of contamination as described by the Chinese authorities.” But without evidence to support pursuing the case, and with the chance of winning an appeal at almost nil, Cottier determined WADA’s “decision not to appeal appears indisputably reasonable.” But how did the drugs get into the kitchen? A mystery remained: How did those traces of TMZ get into the kitchen? Shortly after the doping positives were revealed, the Institute of National Anti-Doping Organizations held a meeting on April 30 where it heard from the leader of China’s agency, Li Zhiquan. Li’s presentation was mostly filled with the same talking points that have been delivered throughout the saga — that the positive tests resulted from contamination from the kitchen. But he expanded on one way the kitchen might have become contaminated, harkening to another case in China involving a low-level TMZ positive. A pharmaceutical factory, he explained, had used industrial alcohol in the distillation process for producing TMZ. The industrial alcohol laced with the drug “then entered the market through illegal channels,” he said. The alcohol “was re-used by the perpetrators to process and produce cooking wine, which is an important seasoning used locally to make beef noodles,” Li said. “The contaminated beef noodles were consumed by that athlete, resulting in an extremely low concentration of TMZ in the positive sample. “The wrongdoers involved have been brought to justice.” New information sent to WADA ... eventually This new information raised eyebrows among the anti-doping leaders listening to Li’s report. So much so that over the next month, several emails ensued to make sure the details about the noodles and wine made their way to WADA lawyers, who could then pass it onto Cottier. Eventually, Li did pass on the information to WADA general counsel Ross Wenzel and, just to be sure, one of the anti-doping leaders forwarded it, as well, according to the emails seen by the AP. All this came with Li’s request that the noodles story be kept confidential. Turns out, it made it into Cottier’s report, though he took the information with a grain of salt. “Indeed, giving it more attention would have required it to be documented, then scientifically verified and validated,” he wrote. Neither Wenzel nor officials at the Chinese anti-doping agency returned messages from AP asking about the noodles conspiracy and the other athlete who Li suggested had been contaminated by them. Meanwhile, 11 of the swimmers who originally tested positive competed at the Paris Games earlier this year in a meet held under the cloud of the Chinese doping case. Though WADA considers the case closed, Koehler and others point to situations like this as one of many reasons that an investigation by someone other than Cottier, who was hired by WADA, is still needed. “It gives the appearance that people are just making things up as they go along on this, and hoping the story just goes away,” Koehler said. “Which clearly it has not.” ___ AP Olympics:Hong Kong to grapple with turbulent market in 2025, finance chief says
Trump is ‘100% serious’ about acquiring Greenland, Panama Canal, say sources close to prez-elect
Maschmeyer's 34 saves carry Ottawa Charge past New York Sirens, 3-1CHICAGO (AP) — When the Chicago Bears threatened to score in the closing minutes of a 6-3 loss to the Seattle Seahawks on Thursday, fans expressed their feelings loud and clear. They weren't cheering for a touchdown or field goal. They had something else in mind. “Sell the team!” they chanted. With their skid at 10 games, a season that started with playoff hopes can't end soon enough for the Bears (4-12). They will wrap it up when they visit the rival Green Bay Packers on Jan. 5. “My job is to go out there and win games,” quarterback Caleb Williams said. “And we don’t focus on the outside noise. The fans are going to cheer and maybe boo sometimes. And you can’t react to that. It’s not something that we react to.” Chicago is 14-36 in three seasons under general manager Ryan Poles and has two double-digit losing streaks. The Bears dropped their final 10 in 2022 when they were tanking as part of a franchise-record 14-game skid that stretched into last year. They've never lost more than 10 in a row in a single season. The slide was at six games when they fired former coach Matt Eberflus the day after a loss at Detroit on Thanksgiving, following a series of poor late-game decisions. They're 0-4 under interim coach Thomas Brown, and they've been dominated by Green Bay in recent decades. What’s working The defense. A defense that has gone from ranking seventh in yards per game through the first six weeks to 25th did its part against Seattle. The six points allowed were a season-low and the 265 yards the Bears gave up were their second-lowest. “As we know, our defense has a certain standard and we’ve showed it,” cornerback Kyler Gordon said. “So, obviously syncing a little bit. Just getting back on the guys to get back right. It’s just important to know what we can do and just go in there and execute.” What needs help Pass protection. Williams was sacked seven times, bringing his NFL-leading total and individual franchise record to 67. The Bears broke their previous mark of 66 sacks allowed in 2004, when they used four quarterbacks. Their issues on the offensive line are well-documented. And so is Williams' tendency to hold onto the ball too long, resulting in unnecessary sacks. “There were miscues,” Williams said. “There were stupid sacks that I was taking, losing 10, 14 yards, which is frustrating. But I will say that I will definitely take the heat for this one just because (of) some of the situations that I put us in.” Stock up DE Montez Sweat. The Bears gave up 53 yards rushing on Seattle's game-opening field-goal drive. But the line performed better after that. Sweat picked up his first sack since Week 12 against Minnesota on the first play of Seattle's second possession, when he took down Geno Smith for an 8-yard loss. Though he's only missed one game, Sweat has been slowed by ankle and shin injuries. His 5 1/2 sacks are a big drop from last season, when he had a combined 12 1/2 for Washington and Chicago while becoming the first NFL player to lead two teams in the same season. Stock down Williams. Coming off a promising outing against NFC leader Detroit that followed some shaky outings, Williams had a rough night. The No. 1 overall draft pick completed 16 of 28 passes for 122 yards — not much more than his low of 93 in a Week 1 win over Tennessee — after throwing for 334 yards and two touchdowns against the Lions. The seven sacks for 46 yards both matched his second-highest totals. Injuries The Bears reported no injuries during the game. Key number 5 — The Bears once again had trouble sustaining drives, converting just 5 of 15 third downs and punting on seven of their 10 possessions. They tied a season low with 11 first downs and managed 179 yards. Chicago owns the NFL's second-worst third-down conversion rate at 31.8% and is averaging a league-worst 287.3 yards per game. Next steps The Bears have lost 11 straight against the Packers — the longest streak by either team in the storied rivalry — and 26 of 29 counting the playoffs. They've dropped eight in a row at Lambeau Field since a win in 2015. ___ AP NFL: https://apnews.com/hub/NFL Andrew Seligman, The Associated Press
Mount Sinai Hospital to Host Sixth International Prostate Cancer Symposium and World Congress of Urologic Oncology
Orthofix Medical ( NASDAQ:OFIX – Get Free Report ) and AngioDynamics ( NASDAQ:ANGO – Get Free Report ) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability. Volatility and Risk Orthofix Medical has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, AngioDynamics has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Insider and Institutional Ownership 89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 2.6% of Orthofix Medical shares are owned by company insiders. Comparatively, 5.4% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Analyst Recommendations Orthofix Medical currently has a consensus target price of $23.00, suggesting a potential upside of 31.20%. AngioDynamics has a consensus target price of $12.00, suggesting a potential upside of 34.68%. Given AngioDynamics’ stronger consensus rating and higher possible upside, analysts plainly believe AngioDynamics is more favorable than Orthofix Medical. Profitability This table compares Orthofix Medical and AngioDynamics’ net margins, return on equity and return on assets. Valuation & Earnings This table compares Orthofix Medical and AngioDynamics”s revenue, earnings per share (EPS) and valuation. Orthofix Medical has higher revenue and earnings than AngioDynamics. Orthofix Medical is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks. Summary AngioDynamics beats Orthofix Medical on 8 of the 14 factors compared between the two stocks. About Orthofix Medical ( Get Free Report ) Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. About AngioDynamics ( Get Free Report ) AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York. Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter .
Plan for ‘super junior’ to tackle immigration issueJoby conducts first FAA testing under Type Inspection Authorization in simulator in Marina
Carrier Board of Directors Announces an 18 Percent Increase in Quarterly Dividend to $0.225 per ShareRonan O'Gara said he was "more than pretty happy" with his side's opening night victory away to Bath in the Champions Cup. The French side won 24-20, holding on in the second half after an opening 40 minutes which looked to have them cruising towards a bonus point win. La Rochelle led 21-6 at the break but added just three points in the second half as the English Premiership leaders fought back. "It's just about getting started and winning," said O'Gara told Premier Sports. "We can look at the content tomorrow, Monday, Tuesday and get better for Bristol. "Brilliant first half, shocking second half. But character from the boys because we could have buckled, but some young fellas put up their hands and we've got a good team spirit. I think the better team won tonight." La Rochelle scored three first half tries through Oscar Jegou, Reda Wardi and Tawera Kerr-Barlow. "We were very accurate," O'Gara said. "It's always really pleasing when you construct a maul like that and you score off it. Then you kind of bluff them into going off the top. Obviously, Tawera showed exceptional hands to be able to control the ball and run through. I suppose the thought process involved in that is interesting. "Our first try was obviously just battering away near the line. So 21 points, which was good. And then we started the second half really poorly. "Backed up errors, discipline, scrum count. Lineout struggled a little bit, but then we got four (match) points, and in these conditions that's great because you can defend like dogs and we defended really well at the end." La Rochelle, struggling in the Top 14 this season, face Bristol at home next weekend. "You have to be smart with the different conditions," said O'Gara, "maybe it could be OK next week because tonight it's a very different rugby to potentially Bristol, how they'd like to play because they throw the ball around and their skill levels are top. "We put teams under pressure a bit and we squeeze them but we can play ball as well. If we get conditions, it's about being smart and opening your game plan or closing it up. "Tonight, for 40 minutes, that obviously won us the game. The boys should be very happy tonight. It's a good reaction from last week's Top 14, but this competition is special and we want to be involved in the knockout stages."
